Pathway: Condensation of Prometaphase Chromosomes
Condensation of Prometaphase Chromosomes
Protein levels of condensin subunits are constant during the cell cycle, however condensins are enriched on mitotic chromosomes. Four of the five subunits, SMC4, NCAPD2, NCAPG and NCAPH, are phosphorylated in both mitotic and interphase HeLa cells, but on different sites (Takemoto et al. 2004). CDK1 (CDC2) in complex with CCNB (cyclin B) phosphorylates NCAPD2, NCAPG and NCAPH in mitosis (Kimura et al. 1998, Kimura et al. 2001, Takemoto et al. 2006, Murphy et al. 2008), but other mitotic kinases, such as PLK1 (St-Pierre et al. 2009), and other post-translational modifications, such as acetylation, may also be involved (reviewed by Bazile et al. 2010). Global proteomic analysis of human cell lines has identified N6-acetylation of lysine residues in condensin subunits SMC2, SMC4 and NCAPH (Choudhary et al. 2009). Another high throughput proteomic study showed that condensin I subunits NCAPD2 and NCAPH are phosphorylated upon DNA damage, probably by ATM or ATR kinase (Matsuoka et al. 2007).
As condensin I is cytosolic, it gains access to chromosomes only after the nuclear envelope breakdown at the start of prometaphase (Ono et al. 2004). Condensin I, activated by CDK1-mediated phosphorylation, promotes hypercondensation of chromosomes that were condensed in prophase through the action of condensin II (Hirota et al. 2004). AURKB may also regulate association of condensin I complex with chromatin (Lipp et al. 2007). Protein phosphatase PP2A acts independently of its catalytic activity to target condensin II complex to chromatin, but does not interact with condensin I (Takemoto et al. 2009). Full activation of condensin I requires dephosphorylation of sites modified by CK2 during interphase (Takemoto et al. 2006). Besides being essential for chromosome condensation in mitosis, condensin I may also contribute to cohesin removal from chromosome arms in prometaphase, but the exact mechanism is not known (Hirota et al. 2004).
A family of protein serine/threonine kinases known as the cyclin-dependent kinases (CDKs) controls progression through the cell cycle. As the name suggests, the kinase activity of the catalytic subunits is dependent on binding to cyclin partners, and control of cyclin abundance is one of several mechanisms by which CDK activity is regulated throughout the cell cycle.
A complex network of regulatory processes determines whether a quiescent cell (in G0 or early G1) will leave this state and initiate the processes to replicate its chromosomal DNA and divide. This regulation, during the Mitotic G1-G1/S phases of the cell cycle, centers on transcriptional regulation by the DREAM complex, with major roles for D and E type cyclin proteins.
Chromosomal DNA synthesis occurs in the S phase, or the synthesis phase, of the cell cycle. The cell duplicates its hereditary material, and two copies of each chromosome are formed. A key aspect of the regulation of DNA replication is the assembly and modification of a pre-replication complex assembled on ORC proteins.
Mitotic G2-G2/M phases encompass the interval between the completion of DNA synthesis and the beginning of mitosis. During G2, the cytoplasmic content of the cell increases. At G2/M transition, duplicated centrosomes mature and separate and CDK1:cyclin B complexes become active, setting the stage for spindle assembly and chromosome condensation at the start of mitotic M phase. Mitosis, or M phase, results in the generation of two daughter cells each with a complete diploid set of chromosomes. Events of the M/G1 transition, progression out of mitosis and division of the cell into two daughters (cytokinesis) are regulated by the Anaphase Promoting Complex.
The Anaphase Promoting Complex or Cyclosome (APC/C) plays additional roles in regulation of the mitotic cell cycle, insuring the appropriate length of the G1 phase. The APC/C itself is regulated by phosphorylation and interactions with checkpoint proteins.
A family of protein serine/threonine kinases known as the cyclin-dependent kinases (CDKs) controls progression through the cell cycle. As the name suggests, the activity of the catalytic subunit is dependent on binding to a cyclin partner. The human genome encodes several cyclins and several CDKs, with their names largely derived from the order in which they were identified. The oscillation of cyclin abundance is one important mechanism by which these enzymes phosphorylate key substrates to promote events at the relevant time and place. Additional post-translational modifications and interactions with regulatory proteins ensure that CDK activity is precisely regulated, frequently confined to a narrow window of activity.
In addition, genome integrity in the cell cycle is maintained by the action of a number of signal transduction pathways, known as cell cycle checkpoints, which monitor the accuracy and completeness of DNA replication during S phase and the orderly chromosomal condensation, pairing and partition into daughter cells during mitosis.
Replication of telomeric DNA at the ends of human chromosomes and packaging of their centromeres into chromatin are two aspects of chromosome maintenance that are integral parts of the cell cycle.
Meiosis is the specialized form of cell division that generates haploid gametes from diploid germ cells, associated with recombination (exchange of genetic material between chromosomal homologs).